Search
oligomannate
Indications:
- approved in China for treating mild-moderate Alzheimer's disease
Mechanism of action:
- chages gut microbiota
- modulates peripheral & central inflammation
General
oligosaccharide
pharmaceutical agents for treatment of Alzheimer's disease (Alzheimer's agent)
References
- George J
Seaweed-Based Drug Approved for Alzheimer's in China -
Oligomannate appears to affect gut microbiota, peripheral inflammation.
MedPage Today, November 4, 2019
https://www.medpagetoday.com/neurology/alzheimersdisease/83117
- Bloomberg Neews. April 26, 2020
Chinese Alzheimer's Drug Gets U.S. Approval for Stateside Trial.
https://www.msn.com/en-us/health/health-news/chinese-alzheimers-drug-gets-us-approval-for-stateside-trial/ar-BB13dbpY